Depending on the exact commercial sector, the name Verve can refer to several distinct organizations, most notably Verve Therapeutics, a clinical-stage genetic medicine company focused on pioneering single-course in vivo gene-editing treatments for cardiovascular diseases, or Verve Group SE, a major digital advertising technology enterprise. Verve Therapeutics gained widespread industry recognition for its advanced base-editing pipeline designed to permanently target disease-driving genes such as PCSK9, while Verve Group operates as an international ad-tech platform providing privacy-first advertising exchange solutions, software development kits, and digital media monetizing tools across European and North American markets.